Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma

BACKGROUND: The development of new therapies for malignant gliomas has been stagnant for decades. Through the promising outcomes in clinical trials of oncolytic virotherapy, there is now a glimmer of hope in addressing this situation. To further enhance the antitumor immune response of oncolytic vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shan, Chai, Hui-Hui, Fang, Xian-Long, Xu, Hou-Shi, Li, Tian-Wen, Tang, Qi-Sheng, Gu, Jin-Fa, Zhang, Kang-Jian, Liu, Xin-Yuan, Shi, Zhi-Feng, Cao, Xue-Ping, Wu, Zan-Yi, Zhou, Liang-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572777/
https://www.ncbi.nlm.nih.gov/pubmed/37841695
http://dx.doi.org/10.1093/noajnl/vdad117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572777/
https://www.ncbi.nlm.nih.gov/pubmed/37841695
http://dx.doi.org/10.1093/noajnl/vdad117

Ejemplares similares